Upgrade to SI Premium - Free Trial

Goldman Sachs Upgrades ResMed (RMD:AU) (RMD) to Buy

July 29, 2019 1:19 AM
Goldman Sachs analyst Chris Cooper upgraded ResMed (RMD:AU) (NYSE: RMD) from Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Hot Upgrades Intl Ratings Upgrades

Next Articles